Related Experiment Video

Updated: Mar 6, 2026

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
04:04

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Published on: July 5, 2024

1.1K

Cyproheptadine: A Potentially Effective Treatment for Functional Gastrointestinal Disorders in Children

Amornluck Krasaelap, Shailender Madani

    Pediatric Annals
    |March 14, 2017
    PubMed

    Insights

    Cyproheptadine may effectively treat functional gastrointestinal disorders in children by targeting gut serotonin pathways. Further research is needed to confirm its long-term benefits for pediatric FGIDs.

    Area of Science:

    • Pediatric Gastroenterology
    • Neurogastroenterology
    • Pharmacology

    Background:

    • Functional gastrointestinal disorders (FGIDs) significantly impair children's quality of life and increase healthcare expenses.
    • Altered gut serotonin is implicated in FGID pathophysiology, affecting gut motility, sensitivity, secretions, and brain-gut interactions.

    Purpose of the Study:

    • To evaluate cyproheptadine, a serotonin antagonist, as a potential therapeutic agent for pediatric FGIDs.
    • To assess the safety and efficacy of cyproheptadine in children diagnosed with FGIDs.

    Main Methods:

    • Review of existing literature and clinical data on cyproheptadine's use in pediatric FGIDs.
    • Analysis of proposed mechanisms involving serotonin in FGID development and treatment.

    Main Results:

    • Cyproheptadine demonstrates potential as a safe and effective treatment for children with FGIDs.
    • The drug's mechanism involves antagonizing serotonin, addressing a key factor in FGID pathophysiology.

    Conclusions:

    • Cyproheptadine presents a promising treatment option for pediatric functional gastrointestinal disorders.
    • Further well-designed, multicenter trials with long-term follow-up are essential to solidify its role in managing pediatric FGIDs.

    More Related Videos

    Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients07:04

    Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

    Published on: February 11, 2017

    20.2K
    Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

    Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

    Published on: August 29, 2025

    610

    Related Concept Videos

    Drugs for Treatment of Constipation-Predominant IBS01:21

    Drugs for Treatment of Constipation-Predominant IBS

    Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
    1.0K
    Drugs for Treatment of Diarrhea-Predominant IBS01:17

    Drugs for Treatment of Diarrhea-Predominant IBS

    Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
    Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
    815
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    575
    Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

    Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

    Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
    1.1K
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    304
    Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

    Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

    Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
    Adsorbents...
    685